TLWM Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$657K Sell
15,401
-367
-2% -$19.9K 0.11% 52
2026
Q1
$989K Buy
15,768
+614
+4% +$49.1K 0.18% 39
2025
Q4
$1.44M Sell
15,154
-294
-2% -$28.8K 0.26% 33
2025
Q3
$1.51M Buy
15,448
+928
+6% +$96.1K 0.27% 32
2025
Q2
$1.56M Buy
14,520
+112
+0.8% +$11.3K 0.3% 30
2025
Q1
$1.45M Buy
14,408
+346
+2% +$34.8K 0.29% 33
2024
Q4
$1.26M Buy
14,062
+531
+4% +$46.7K 0.25% 35
2024
Q3
$1.13M Sell
13,531
-259
-2% -$20.4K 0.23% 38
2024
Q2
$1.06M Buy
13,790
+252
+2% +$18.4K 0.23% 39
2024
Q1
$927K Buy
+13,538
New +$870K 0.21% 41

Other funds holding BSX

TLWM Financial's BSX Position: Q2 2026 in Review

TLWM Financial reduced its Boston Scientific (BSX) stake by 2.3% in Q2 2026, selling an estimated $19.9K and leaving 15,401 shares worth $657K. The position accounts for 0.11% of the portfolio, ranked #52.

TLWM Financial first reported a position in BSX in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.56M in Q2 2025. 179 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • TLWM Financial held 15,401 shares of Boston Scientific worth $657K as of Q2 2026.
  • TLWM Financial sold 367 Boston Scientific shares in Q2 2026, an estimated $19.9K.
  • Boston Scientific made up 0.11% of TLWM Financial's portfolio in Q2 2026, its #52 holding.
  • TLWM Financial first reported a position in Boston Scientific in Q1 2024 and has held it in 10 quarters since.
  • TLWM Financial's Boston Scientific position peaked at $1.56M in Q2 2025.
  • 179 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on TLWM Financial's 13F filing for Q2 2026, filed 7 Jul 2026.